Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001424411-09-000005
Filing Date
2009-01-20
Accepted
2009-01-20 19:19:42
Documents
1
Period of Report
2009-01-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3844
  Complete submission text file 0001424411-09-000005.txt   5793
Mailing Address 115 SANSOME STREET, SUITE 310 SAN FRANCISCO CA 94104
Business Address 115 SANSOME STREET, SUITE 310 SAN FRANCISCO CA 94104 (415) 875-7880
Nile Therapeutics, Inc. (Issuer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address NILE THERAPEUTICS, INC. 122 OCEAN PARK BLVD., SUITE 307 SANTA MONICA CA 90405
Business Address (510) 281 - 7701
Evans Daron (Reporting) CIK: 0001411726 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34058 | Film No.: 09535566